Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Bone scintigraphy in metastatic bone disease].

K Itoh1

  • 1Department of Radiology, JR Sapporo General Hospital.

Kaku Igaku. the Japanese Journal of Nuclear Medicine
|March 14, 2000
PubMed
Summary

Bone scintigraphy is a sensitive whole-body screening tool for metastatic bone disease. Future improvements in imaging and radiopharmaceuticals are needed to enhance its specificity and cost-effectiveness compared to CT and MRI.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Abnormal chest shadow on CT in immunosuppressed patients].

Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica·1992
Same author

Cytokine regulation of hemostatic property and IL-6 production of human endothelial cells.

Inflammation·1992
Same author

Proliferation and differentiation of fetal liver cells transplanted into rat spleen.

Transplantation proceedings·1992
Same author

Distributions of the Nd and P300 in a normal sample.

International journal of psychophysiology : official journal of the International Organization of Psychophysiology·1992
Same author

Saphenous vein graft to the distal vertebral artery between C-1 and C-2 using a lateral-anterior approach. Technical note.

Journal of neurosurgery·1992
Same author

Single photon emission computed tomography using 201Tl chloride in pulmonary nodules: comparison with 67Ga citrate and 99mTc-labeled hexamethylpropyleneamine-oxime.

Annals of nuclear medicine·1992

Area of Science:

  • Nuclear medicine
  • Oncology
  • Radiology

Background:

  • Bone scintigraphy is a standard diagnostic tool for evaluating metastatic bone disease.
  • It offers high sensitivity and whole-body coverage for lesion detection.
  • Its use is being re-evaluated due to lower specificity and higher costs compared to CT and MRI.

Purpose of the Study:

  • To discuss the current role and future directions of bone scintigraphy in metastatic bone disease evaluation.
  • To address the limitations of bone scintigraphy regarding specificity and cost.
  • To explore strategies for maintaining its utility as a screening test.

Main Methods:

  • Review of current clinical practices and literature on bone scintigraphy for bone metastases.
  • Comparison of bone scintigraphy with advanced imaging modalities like CT and MRI.
  • Discussion of potential advancements in imaging techniques and radiopharmaceuticals.

Main Results:

  • Bone scintigraphy demonstrates high sensitivity for detecting bone metastases.
  • Specificity remains a challenge, leading to potential overdiagnosis or misdiagnosis.
  • Emerging technologies like CT and MRI offer higher specificity but may lack whole-body screening capabilities.

Conclusions:

  • Bone scintigraphy remains valuable for initial screening due to its sensitivity and whole-body assessment.
  • Improving specificity through optimized imaging protocols and novel radiopharmaceuticals is crucial.
  • Further research is needed to integrate bone scintigraphy effectively alongside CT and MRI in clinical practice.

Related Experiment Videos